XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities    
Net income $ 593.4 $ 441.7
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation, amortization and impairment of property, equipment and software 62.6 58.8
Amortization and impairment of acquisition-related assets and retention arrangements 50.8 48.2
Fair value remeasurement of contingent consideration liability 0.0 (49.6)
Stock-based compensation expense 58.4 58.8
Net gains recognized on investments (147.0) (102.3)
Net redemptions in sponsored investment products used to economically hedge supplemental savings plan liability 15.1 18.4
Net change in securities held by consolidated sponsored investment products (158.3) (200.7)
Other changes in assets and liabilities 162.3 238.4
Net cash provided by operating activities 637.3 511.7 Close
Cash flows from investing activities    
Purchases of sponsored investment products (4.5) (8.4)
Dispositions of sponsored investment products 95.7 14.7
Net cash of sponsored investment products on deconsolidation (0.1) (2.5)
Additions to property, equipment and software (102.5) (60.7)
Other investing activity 2.8 (0.6)
Net cash used in investing activities (8.6) (57.5) Close
Cash flows from financing activities    
Repurchases of common stock (83.1) (8.2)
Common share issuances under stock-based compensation plans 14.2 8.0
Dividends paid to common stockholders of T. Rowe Price (286.5) (282.2)
Net contributions to non-controlling interests in consolidated entities 0.2 0.2
Net subscriptions from redeemable non-controlling interest holders 87.4 138.0
Net cash used in financing activities (267.8) (144.2) Close
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products (0.8) 1.5 Close
Net change in cash and cash equivalents during period 360.1 311.5 Close
Cash and cash equivalents at beginning of period, including $77.2 million at December 31, 2023, and $119.1 million at December 31, 2022, held by consolidated sponsored investment products 2,143.8 1,874.7
Cash and cash equivalents at end of period, including $87.4 million at March 31, 2024, and $92.1 million at March 31, 2023, held by consolidated sponsored investment products $ 2,503.9 $ 2,186.2